Pacific Biosciences Of California | PACB - Trade Debtors


Pacific Biosciences Of California reported $35.45M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
Agilent USD 1.5B 23M Mar/2026
Bruker USD 542.7M 2.2M Mar/2026
Danaher USD 4.76B 845M Mar/2026
General Electric Aerospace USD 22.18B 6.89B Mar/2026
Illumina USD 738M 116M Mar/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
Pacific Biosciences Of California USD 35.45M 4.83M Dec/2025
Quidel USD 359.9M 57.1M Mar/2026
Revvity USD 691.38M 53.29M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Standard Biotools USD 41.64M 28.21M Mar/2026
Thermo Fisher Scientific USD 9.2B 304M Mar/2026
Waters USD 1.76B 930.16M Mar/2026